NEW YORK (GenomeWeb) — Agbiome, a developer of microbe-based agricultural technologies, announced today that it has struck a deal to develop crop-protection products with ag-bio giant Syngenta.

Under the multi-year deal, Syngenta will fund AgBiome's development of undisclosed plant-protection technologies for crops of interest. Specific terms of the arrangement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.